Hims Just Folded to Big Pharma? The Ozempic Power Move Explained episode artwork

EPISODE · Jun 15, 2026 · 9 MIN

Hims Just Folded to Big Pharma? The Ozempic Power Move Explained

from Decoding Health · host Dr. Urban A. Kiernan

Send us Fan MailJoin Dr. Urban A. Kiernan as he decodes the complex business of science, focusing on the recent legal battles and market dynamics surrounding GLP-1 medications. This episode dives deep into the dispute between Novo Nordisk and Hims & Hers over patented drugs like Wegovy and Ozempic, and the implications for compounded versions. Learn how intellectual property protection shapes the pharmaceutical landscape, influences drug accessibility, and impacts consumer costs. Dr. Kiernan explains the intricacies of drug development, legal challenges, and the evolving market for innovative therapies, empowering you with crucial insights into the health industry.What You'll Learn:The importance of proprietary molecules and patent law in pharmaceuticals.How legal disputes between drug companies can impact market availability.The business decisions behind distributing branded versus compounded medications.The role of intellectual property in recouping drug development costs.Insights into emerging molecules like Retatrutide and future market trends. Stay informed about the evolving world of health and medicine! #DecodingHealth #BusinessOfScience #GLP1 #PharmaLaw #DrugDevelopmentAre you eager to explore more about health and wellness? Discover an all natural solution to combating the GLP-1 Receptor Agonist craze. Click on the link below and explore the Feel Great System - a clinically proven approach to boosting natural GLP-1 production, suppressing appetite and improving both your metabolism and weight.https://ufeelgreat.com/usa/en/c/LiveFreeAs a Decoding Health viewer, you get wholesale pricing and a money back guarantee. Give it a try and let us know your results.https://imbiopharma.com/https://www.linkedin.com/in/urban-a-kiernan-ph-d-8568b621/https://www.youtube.com/@DecodingHealthPodcastThank you to our sponsor - iMetabolic Biopharma Corporation: Together, we can be the next stage in developing a revolutionary approach to drug discovery.  We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable. Visit https://imbiopharma.com/ to learn more.This show is proudly produced at PS Studios — learn more https://www.psstudios.co

Episode metadata supplied by the publisher feed · Published Jun 15, 2026

Embed this episode

Send us Fan Mail Join Dr. Urban A. Kiernan as he decodes the complex business of science, focusing on the recent legal battles and market dynamics surrounding GLP-1 medications. This episode dives deep into the dispute between Novo Nordisk and Hims & Hers over patented drugs like Wegovy and Ozempic, and the implications for compounded versions. Learn how intellectual property protection shapes the pharmaceutical landscape, influences drug accessibility, and impacts consumer costs. Dr. Kie...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Hims Just Folded to Big Pharma? The Ozempic Power Move Explained

0:00 9:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Decoding Health?

This episode is 9 minutes long.

When was this Decoding Health episode published?

This episode was published on June 15, 2026.

Can I download this Decoding Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!